Limitations of stereotactic biopsy in the initial management of gliomas
- PMID: 11465400
- PMCID: PMC1920616
- DOI: 10.1093/neuonc/3.3.193
Limitations of stereotactic biopsy in the initial management of gliomas
Abstract
Stereotactic biopsy is often performed for diagnostic purposes before treating patients whose imaging studies highly suggest glioma. Indications cited for biopsy include diagnosis and/or the "inoperability" of the tumor. This study questions the routine use of stereotactic biopsy in the initial management of gliomas. At The University of Texas M. D. Anderson Cancer Center, we retrospectively reviewed a consecutive series of 81 patients whose imaging studies suggested glioma and who underwent stereotactic biopsy followed by craniotomy/resection (within 60 days) between 1993 and 1998. All relevant clinical and imaging information was reviewed, including computerized volumetric analysis of the tumors based on pre- and postoperative MRI. Stereotactic biopsy was performed at institutions other than M. D. Anderson in 78 (96%) of 81 patients. The majority of tumors were located either in eloquent brain (36 of 81 = 44%) or near-eloquent brain (41 of 81 = 51%), and this frequently was the rationale cited for performing stereotactic biopsy. Gross total resection (>95%) was achieved in 46 (57%) of 81 patients, with a median extent of resection of 96% for this series. Diagnoses based on biopsy or resection in the same patient differed in 40 (49%) of 82 cases. This discrepancy was reduced to 30 (38%) of 80 cases when the biopsy slides were reviewed preoperatively by each of three neuropathologists at M. D. Anderson. Major neurologic complications occurred in 10 (12.3%) of 81 surgical patients and 3 (3.7%) of 81 patients undergoing biopsy. Surgical morbidity was probably higher in our series than it would be for glioma patients in general because our patients represent a highly selected subset of glioma patients whose tumors present a technical challenge to remove. Stereotactic biopsy is frequently inaccurate in providing a correct diagnosis and is associated with additional risk and cost. If stereotactic biopsy is performed, expert neuropathology consultation should be sought.
Similar articles
-
MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen.Surg Neurol. 2003 Apr;59(4):277-81; discussion 281-2. doi: 10.1016/s0090-3019(03)00048-x. Surg Neurol. 2003. PMID: 12748009 Clinical Trial.
-
Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen.Neurol Res. 2005 Jun;27(4):358-62. doi: 10.1179/016164105X40057. Neurol Res. 2005. PMID: 15949232
-
Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?Minim Invasive Neurosurg. 2008 Oct;51(5):275-9. doi: 10.1055/s-0028-1082322. Epub 2008 Oct 14. Minim Invasive Neurosurg. 2008. PMID: 18855292
-
Stereotactic resection and its limitations in glial neoplasms.Stereotact Funct Neurosurg. 1992;59(1-4):84-91. doi: 10.1159/000098922. Stereotact Funct Neurosurg. 1992. PMID: 1295051 Review.
-
Multimodality program involving stereotactic surgery in brain tumor management.Stereotact Funct Neurosurg. 2000;75(2-3):147-52. doi: 10.1159/000048397. Stereotact Funct Neurosurg. 2000. PMID: 11740184 Review.
Cited by
-
Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid.Clin Epigenetics. 2024 Jul 5;16(1):87. doi: 10.1186/s13148-024-01696-w. Clin Epigenetics. 2024. PMID: 38970137 Free PMC article.
-
MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas.AJNR Am J Neuroradiol. 2005 Apr;26(4):777-83. AJNR Am J Neuroradiol. 2005. PMID: 15814920 Free PMC article.
-
Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?AJNR Am J Neuroradiol. 2009 Apr;30(4):681-8. doi: 10.3174/ajnr.A1465. Epub 2009 Jan 29. AJNR Am J Neuroradiol. 2009. PMID: 19179427 Free PMC article.
-
Cerebral blood volume calculated by dynamic susceptibility contrast-enhanced perfusion MR imaging: preliminary correlation study with glioblastoma genetic profiles.PLoS One. 2013 Aug 19;8(8):e71704. doi: 10.1371/journal.pone.0071704. eCollection 2013. PLoS One. 2013. PMID: 23977117 Free PMC article.
-
Arterial spin labeling MR imaging for differentiation between high- and low-grade glioma-a meta-analysis.Neuro Oncol. 2018 Oct 9;20(11):1450-1461. doi: 10.1093/neuonc/noy095. Neuro Oncol. 2018. PMID: 29868920 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical